Chronic Lymphocytic Leukaemia

book icon

Gilead 133

A Phase 2, Single Arm Study Evaluating the Efficacy and Safety of Idelalisib in Combination with Rituximab in Patients with Previously Untreated Chronic Lymphocytic Leukemia with 17p Deletion

book icon

GALACTIC

GA-101 (obinutuzumab) monocLonal Antibody as Consolidation Therapy In CLL

book icon

COSMIC

Combination FC plus Ofatumumab at Standard or Mega dose In CLL

book icon

RIALTO

RIAltO: A Randomised Investigation of Alternative Ofatumumabcontaining regimens in less fit patients with CLL

book icon

CLL210 (OfaDexRev)

A Phase II Trial of Ofatumumab, Dexamethasone and Lenalidomide Followed by Randomisation to Lenalidomide Maintenance Versus No Further Treatment for High-Risk CLL.

book icon

CLL Lenalidomide Maintanence 002 – The Continuum Trial

A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF THE EFFICACY AND SAFETY OF LENALIDOMIDE (REVLIMID®) AS MAINTENANCE THERAPY FOR PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA FOLLOWING SECOND-LINE THERAPY (The Continuum Trial)